Vora N L, O’Brien B M. Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution[J]. Obstet Gynecol, 2014, 123(5): 1097-1099. [2]Dan S, Wang W, Ren J, et al. Clinical application of massively parallel sequencing-based prenatal noninvasive fetal trisomy test for trisomies 21 and 18 in 11, 105 pregnancies with mixed risk factors[J]. Prenat Diagn, 2012, 32(13): 1225-1232. [3]Srinivasan A, Bianchi D W, Huang H, et al. Noninvasive detection of fetal subchromosome abnormalities via deep sequencing of maternal plasma[J]. Am J Hum Genet, 2013, 92(2): 167-176. [4]Fu F, Liu H L, Li R, et al. Prenatal diagnosis of foetuses with congenital abnormalities and duplication of the MECP2 region[J]. Gene, 2014, 546(2): 222-225. [5]Artuso R, Papa F T, Grillo E, et al. Investigation of modifier genes within copy number variations in Rett syndrome[J]. J Hum Genet. 2011, 56(7): 508-515. [6]Hung C C, Lin C H, Lin S Y, et al. Prenatal diagnosis of a fetus with a de novo trisomy 12p by array-comparative genomic hybridization (array-CGH) [J]. Gene, 2012, 495(2): 178-182. [7]Simpson J L, Bischoff F. Cell-free fetal DNA in maternal blood: evolving clinical applications[J]. JAMA, 2004, 291(9): 1135-1137. [8]Lau T K, Chen F, Pan X, et al. Noninvasive prenatal diagnosis of common fetal chromosomal aneuploidies by maternal plasma DNA sequencing[J]. J Matern Fetal Neonatal Med, 2012, 25(8): 1370- 1374. [9]Miller D T, Adam M P, Aradhya S, et al. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies[J]. Am J Hum Genet, 2010, 86(5): 749-764. [10]Lo Y M, Chan K C, Chiu R W. Nonivasive fetal trisomy 21 delection using chromosome-selective sequencing: a variation of the molecular counting theme[J]. Expert Rev Mol Diagn, 2012, 12(4): 329-331.
